Kaken Pharmaceutical Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Hiroyuki Horiuchi
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.4yrs |
| CEO ownership | 0.02% |
| Management average tenure | no data |
| Board average tenure | 2.9yrs |
Recent management updates
CEO
Hiroyuki Horiuchi (62 yo)
4.4yrs
Tenure
Mr. Hiroyuki Horiuchi serves as Director of Kaken Pharmaceutical Co. Ltd. since June 2016 and has been its President since June 2020. He is the Chairman of Kaken Pharmaceutical Co. Ltd.He was Chief Office...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 8.4yrs | no data | 0.020% ¥ 34.3m | |
| MD & Director | 3.4yrs | no data | 0.0084% ¥ 14.3m | |
| Head of Research and Development & Director | 1.4yrs | no data | 0.0063% ¥ 10.7m | |
| Independent Outside Director | 4.4yrs | no data | 0.0013% ¥ 2.2m | |
| Independent Outside Director | 3.4yrs | no data | 0.00026% ¥ 439.3k | |
| Outside Audit & Supervisory Board Member | 1.4yrs | no data | 0.00026% ¥ 439.3k | |
| Auditor | 1.4yrs | no data | 0.015% ¥ 25.9m | |
| Director | 4.4yrs | no data | 0.014% ¥ 24.1m | |
| Director | less than a year | no data | no data | |
| Outside Audit & Supervisory Board Member | 3.4yrs | no data | 0.0011% ¥ 1.8m | |
| Standing Audit & Supervisory Board Member | 2.4yrs | no data | 0.0050% ¥ 8.5m | |
| Independent Outside Director | less than a year | no data | no data |
2.9yrs
Average Tenure
61.5yo
Average Age
Experienced Board: 4521's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.